close
MENU
Hot Topic Hawke’s Bay
Hot Topic Hawke’s Bay
General Business
4 mins to read

New Zealand cannabis industry ripe for big pharma acquisitions

MedCan Summit lays out expectations on the industry’s future.

Andrew Bevin Thu, 10 Feb 2022

Consolidation is the future of the medical cannabis industry, according to today’s speakers at the national industry summit, MedCan 2022.

During a chief executive panel event at the conference, NZX-listed Rua Bioscience co-founder Manu Caddie (standing in for CEO Rob Mitchell) said he expected

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Andrew Bevin Thu, 10 Feb 2022
Contact the Writer: andrew@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
New Zealand cannabis industry ripe for big pharma acquisitions
General Business,
90450
true